Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;24(6):623-30.
doi: 10.1111/bpa.12198.

Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Affiliations
Review

Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!

Myka L Estes et al. Brain Pathol. 2014 Nov.

Abstract

Neuroinflammation was once a clearly defined term denoting pathological immune processes within the central nervous system (CNS). Historically, this term was used to indicate the four hallmarks of peripheral inflammaton that occur following severe CNS injuries, such as stroke, injury or infection. Recently, however, the definition of neuroinflammation has relaxed to the point that it is often now assumed to be present when even only a single classical hallmark of inflammation is measured. As a result, a wide range of disorders, from psychiatric to degenerative diseases, are now assumed to have an integral inflammatory component. Ironically, at the same time, research has revealed unexpected nonclassical immune actions of immune mediators and cells in the CNS in the absence of pathology, increasing the likelihood that homeostatic and adaptive immune processes in the CNS will be mistaken for neuroinflammation. Thus, we suggest reserving the term neuroinflammation for contexts where multiple signs of inflammation are present to avoid erroneously classifying disorders as inflammatory when they may instead be caused by nonimmune etiologies or secondary immune processes that serve adaptive roles.

Keywords: Alzheimer's disease; T cells; autism; cytokines; microglia; schizophrenia.

PubMed Disclaimer

References

    1. Abbas AK, Lichtman AH, Pillai S (2012) Cellular and Molecular Immunology, 7th edn. Elsevier/Saunders: Philadelphia.
    1. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14:1142–1149. - PubMed
    1. Alvarez A, Cacabelos R, Sanpedro C, Garcia‐Fantini M, Aleixandre M (2007) Serum TNF‐alpha levels are increased and correlate negatively with free IGF‐I in Alzheimer disease. Neurobiol Aging 28:533–536. - PubMed
    1. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116–1122. - PubMed
    1. Ashwood P, Krakowiak P, Hertz‐Picciotto I, Hansen R, Pessah I, Van de Water J (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–45. - PMC - PubMed

Publication types